Ifm Investors Pty LTD Abbott Laboratories Transaction History

Ifm Investors Pty LTD

$10.3 Billion
Q3 2024

A detailed history of Ifm Investors Pty LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Ifm Investors Pty LTD holds 355,617 shares of ABT stock, worth $47.2 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

355,617

Previous 355,671 0.02%

Holding current value

$47.2 Million

Previous $37 Million 9.7%

% of portfolio

0.39%

Previous 0.38%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$100.07 - $118.13 $5,403 - $6,379	-54 Reduced 0.02%	355,617 $40.5 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $63,056 - $70,387	626 Added 0.18%	355,671 $37 Million
Q1 2024 Apr 22, 2024	SELL	$109.52 - $120.96 $48,955 - $54,069	-447 Reduced 0.13%	355,045 $40.4 Million
Q4 2023 Jan 12, 2024	BUY	$90.19 - $110.4 $374,198 - $458,049	4,149 Added 1.18%	355,492 $39.1 Million
Q3 2023 Oct 26, 2023	BUY	$95.53 - $114.62 $1.07 Million - $1.28 Million	11,196 Added 3.29%	351,343 $34 Million
Q2 2023 Jul 27, 2023	BUY	$100.78 - $112.29 $1.97 Million - $2.2 Million	19,582 Added 6.11%	340,147 $37.1 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $859,535 - $1.01 Million	8,874 Added 2.85%	320,565 $32.5 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.14 Million - $1.34 Million	11,985 Added 4.0%	311,691 $34.2 Million
Q3 2022 Oct 12, 2022	BUY	$96.76 - $112.03 $173,877 - $201,317	1,797 Added 0.6%	299,706 $29 Million
Q2 2022 Jul 15, 2022	BUY	$102.07 - $123.37 $1.85 Million - $2.23 Million	18,098 Added 6.47%	297,909 $32.4 Million
Q1 2022 Apr 13, 2022	BUY	$114.02 - $139.04 $5.54 Million - $6.76 Million	48,604 Added 21.02%	279,811 $33.1 Million
Q4 2021 Jan 18, 2022	SELL	$115.53 - $141.46 $378,014 - $462,857	-3,272 Reduced 1.4%	231,207 $32.5 Million
Q3 2021 Oct 13, 2021	BUY	$116.66 - $129.06 $18,315 - $20,262	157 Added 0.07%	234,479 $27.7 Million
Q2 2021 Jul 16, 2021	BUY	$105.79 - $124.53 $4.45 Million - $5.24 Million	42,088 Added 21.89%	234,322 $27.2 Million
Q1 2021 May 05, 2021	BUY	$108.84 - $128.23 $2.31 Million - $2.72 Million	21,238 Added 12.42%	192,234 $23 Million
Q4 2020 Jan 13, 2021	BUY	$105.0 - $114.42 $2.53 Million - $2.75 Million	24,049 Added 16.37%	170,996 $18.7 Million
Q3 2020 Oct 16, 2020	BUY	$91.64 - $111.29 $1.55 Million - $1.88 Million	16,884 Added 12.98%	146,947 $16 Million
Q2 2020 Jul 13, 2020	SELL	$76.57 - $98.0 $4 Million - $5.12 Million	-52,213 Reduced 28.65%	130,063 $11.9 Million
Q1 2020 Apr 09, 2020	SELL	$62.82 - $91.86 $344,630 - $503,943	-5,486 Reduced 2.92%	182,276 $14.5 Million
Q4 2019 Jan 13, 2020	SELL	$78.51 - $87.4 $221,947 - $247,079	-2,827 Reduced 1.48%	187,762 $16.3 Million
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $5.56 Million - $6.02 Million	67,891 Added 55.33%	190,589 $15.9 Million
Q2 2019 Jul 16, 2019	BUY	$72.88 - $85.0 $708,612 - $826,455	9,723 Added 8.61%	122,698 $10.3 Million
Q1 2019 Apr 18, 2019	BUY	$66.22 - $80.06 $757,424 - $915,726	11,438 Added 11.26%	112,975 $9.03 Million
Q4 2018 Jan 23, 2019	BUY	$65.56 - $74.27 $589,777 - $668,132	8,996 Added 9.72%	101,537 $7.34 Million
Q3 2018 Oct 22, 2018	BUY	$60.81 - $73.36 $827,867 - $998,723	13,614 Added 17.25%	92,541 $6.79 Million
Q2 2018 Jul 09, 2018	BUY	$57.57 - $63.54 $1.43 Million - $1.57 Million	24,754 Added 45.69%	78,927 $4.81 Million
Q1 2018 May 11, 2018	BUY	$56.27 - $63.62 $307,177 - $347,301	5,459 Added 11.21%	54,173 $3.25 Million
Q4 2017 Jan 29, 2018	BUY	$53.68 - $57.47 $3,059 - $3,275	57 Added 0.12%	48,714 $2.78 Million
Q3 2017 Nov 16, 2017	BUY	$48.06 - $53.64 $70,648 - $78,850	1,470 Added 3.12%	48,657 $2.6 Million
Q2 2017 Aug 10, 2017	BUY	N/A	12,223 Added 34.96%	47,187 $2.29 Million
Q1 2017 Aug 17, 2017	BUY	N/A	34,964	34,964 $1.55 Million

Others Institutions Holding ABT

# of Institutions

3,372

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $232B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.

Account

Ifm Investors Pty LTD Abbott Laboratories Transaction History